Current Issue
From Aberrant Results to Alternative Methods: Strengthening Pharmaceutical Laboratory Deci...
Dr Markus Funk, Operations Director Analytics Axel. H. Schroeder, Operations Director Micr...
Sterility Assurance – An Enabler to Comply with Annex 1
Robert Dream, Managing Director, HDR Company LLC
Harmonization of Viral Segregation Strategy for a Manufacturing Network with Multiple Faci...
Bonnie K. Shum, Senior Director, Product Technical Leader, Genentech
Raw Material Qualification – A Practical Approach
Aurora Henry, GMP Quality/ Raw Material Quality/Material Control Leader
Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH
JSR Life Sciences
Featured Articles
Accelerating the Commercialization of Biosimilar Medicines in India
Sartorius Stedim Biotech
Process Analytical Technology For Upstream Bioprocessing
Erica Fratz-Berilla and Cyrus Agarabi, FDA CDER
Comparison of purification performance of Amsphere A3 to other commercially available Protein A resins
Successful Wetting for Filter Integrity Testing in Volume-Restricted Systems
View All Featured ArticlesHeadline News
Andelyn partners with Celliaz to manufacture AAV gene therapy for retinitis pigmentosa
CAPLYTA shows rapid improvement in bipolar mania in second pivotal Phase III study
Zura Bio discontinues tibulizumab development in hidradenitis suppurativa after Phase II miss
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Continuous Capture and Continuous Recovery – Novel Ideas for Product Recovery from Perfusion Process Using ATF
Presented by Dr. Kerstin Lange, Team Lead Process Technology and Innovation, Advanced Bioprocessing, Andrew Falconbridge Vice President Process Technology and Innovation, Alvotech and Earl Pineda Sr. Manager, Upstream Field Applications EU/APAC at Repligen
03rd February 2021
FDA Perspective on Aseptic Process Simulation for Cell Therapy Product Manufacturing
Presented by Lily Koo, Consumer Safety Officer at Food and Drug Administration and Keen Chung, Principal Scientist (Upstream Process) at Pall Biotech, Analytics Lead
16th October 2019
Assessing the Risk of Interaction Between Extractables and Leachable and Therapeutic Proteins
Presented by Andrew Teasdale, Senior Principal Scientist Impurity management and External Advocacy at AstraZeneca & Piet Christieans, PhD, Scientific Director at Nelson Lab
14th May 2020
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
From Compliance to Circularity: Three Ways Pharma Manufacturers Can Rethink Resource Management
Push-Button Simplicity: Automatic Fermentation with the BioFlo® 120 Auto Culture Mode
Rationale Design of Valves for Flexible Processing
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products















